Abstract

Alzheimer’s (AD) and Parkinson’s (PD) are respectivamente chronic, progressive and incurable neurodegenerative diseases. AD is one of the most common forms of dementia and is related to the loss of cognitive function, memory Affecting, language and behavior. PD, in turn, Mainly Affects motor coordination, tremors Causing and Difficulties in movement. The diagnosis is based on the patient’s clinical history and behavioral observation, Which manifests in later stages of the disease. Magnetic resonance tomography and help in the investigation and exclusion of other pathologies. When other hypotheses are excluded, the doctor can confirm the diagnosis Then. It is called the differential diagnosis. In the search for more precious methods to investigate These diseases, diseases. Research on the socalled biomarkers CFS has shown promise and has a strong potential for clinical application in the near future, contributing to the advancement of medicine and the consequent improvement in the treatment of its carriers.

Keywords: Alzheimer’s; Parkinson’s; Cerebrospinal Fluid; Laboratory Diagnosis